162 related articles for article (PubMed ID: 11981808)
1. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells.
Stunz LL; Lenert P; Peckham D; Yi AK; Haxhinasto S; Chang M; Krieg AM; Ashman RF
Eur J Immunol; 2002 May; 32(5):1212-22. PubMed ID: 11981808
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
Lenert P; Yi AK; Krieg AM; Stunz LL; Ashman RF
Antisense Nucleic Acid Drug Dev; 2003; 13(3):143-50. PubMed ID: 12954114
[TBL] [Abstract][Full Text] [Related]
3. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
4. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
Yi AK; Chang M; Peckham DW; Krieg AM; Ashman RF
J Immunol; 1998 Jun; 160(12):5898-906. PubMed ID: 9637502
[TBL] [Abstract][Full Text] [Related]
5. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.
Du HY; Xia SY; Song HF; Li N; Shang MM; Zou J; Wang QQ; Ou L; Sun X; Ji AG; Tang ZM
Acta Pharmacol Sin; 2007 Oct; 28(10):1637-44. PubMed ID: 17883951
[TBL] [Abstract][Full Text] [Related]
6. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
Wattrang E
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):218-28. PubMed ID: 19447503
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
Britigan BE; Lewis TS; Waldschmidt M; McCormick ML; Krieg AM
J Immunol; 2001 Sep; 167(5):2921-8. PubMed ID: 11509640
[TBL] [Abstract][Full Text] [Related]
8. Sequence requirements for oligodeoxyribonucleotide inhibitory activity.
Ashman RF; Goeken JA; Drahos J; Lenert P
Int Immunol; 2005 Apr; 17(4):411-20. PubMed ID: 15746247
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody.
Chen W; Yu Y; Shao C; Zhang M; Wang W; Zhang L; Cao X
Immunol Lett; 2001 May; 77(1):17-23. PubMed ID: 11348665
[TBL] [Abstract][Full Text] [Related]
10. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
[TBL] [Abstract][Full Text] [Related]
11. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
Macfarlane DE; Manzel L; Krieg AM
Immunology; 1997 Aug; 91(4):586-93. PubMed ID: 9378499
[TBL] [Abstract][Full Text] [Related]
12. Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.
Castro JE; Prada CE; Aguillon RA; Kitada S; Fukuda T; Motta M; Wu C; Dicker F; Sun G; Wang JY; Carson DA; Reed JC; Kipps TJ
Leukemia; 2006 Apr; 20(4):680-8. PubMed ID: 16498393
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells.
Lenert P; Rasmussen W; Ashman RF; Ballas ZK
DNA Cell Biol; 2003 Oct; 22(10):621-31. PubMed ID: 14611683
[TBL] [Abstract][Full Text] [Related]
14. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
15. Effect of suppressive DNA on CpG-induced immune activation.
Yamada H; Gursel I; Takeshita F; Conover J; Ishii KJ; Gursel M; Takeshita S; Klinman DM
J Immunol; 2002 Nov; 169(10):5590-4. PubMed ID: 12421936
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
Macfarlane DE; Manzel L
J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
[TBL] [Abstract][Full Text] [Related]
17. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
[TBL] [Abstract][Full Text] [Related]
18. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.
Krieg AM
Biochim Biophys Acta; 1999 Dec; 1489(1):107-16. PubMed ID: 10807001
[TBL] [Abstract][Full Text] [Related]
20. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
Zelenay S; Elías F; Fló J
Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
